Monitoring recovery after BodyTite and FaceTite procedures with a wearable sensor vest
Evaluation of Non-Invasive Assessment for Post RFAL Procedure Monitoring Using the Nanowear Wearable Multiple Sensor Vest
This study tests if a special wearable vest can help track how well patients recover after BodyTite and FaceTite surgeries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nanowear Inc. Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT04721405 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of the Nanowear wearable multiple sensor vest for post-operative monitoring in patients undergoing BodyTite and FaceTite procedures. Participants will wear the vest for at least 12 hours daily over a period of 48 hours to 7 days following their surgery. The study focuses on collecting data on patient recovery experiences without any active intervention. The goal is to assess how well the vest can monitor vital signs and other health metrics during the recovery phase.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are scheduled for BodyTite and/or FaceTite procedures and can comply with the study requirements.
Not a fit: Patients with pacemakers, internal defibrillators, or other active electrical implants, as well as those who are pregnant or nursing, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance post-operative care by providing continuous, non-invasive monitoring of patients' recovery.
How similar studies have performed: While the use of wearable technology for monitoring has been explored in various contexts, this specific application in post-operative plastic surgery is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed informed consent to participate in the study. * Female and male subjects, at least 18 years of age at the time of enrolment * The patient is scheduled to undergo BodyTite and/or FaceTite procedures. * The patients should be willing to comply with the study procedure and schedule. Exclusion Criteria: * Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body. * Pregnancy and nursing. * Subject unwilling or unable to comply with wearing the Nanowear System 12 hours daily for at least 48 hours Up to 7 days * As per the practitioner's discretion, refrain from treating any condition that might make it unsafe for the patient
Where this trial is running
New York, New York
- Zucker School of Medicine, Hofstra University — New York, New York, United States (Recruiting)
Study contacts
- Study coordinator: Maria Shusterman
- Email: maria.shusterman@inmodemd.com
- Phone: 4164589001
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.